Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue.

Elsayed M, Magistretti PJ.

Front Cell Neurosci. 2015 Dec 16;9:468. doi: 10.3389/fncel.2015.00468. eCollection 2015. Review.

2.

Imaging cerebral tryptophan metabolism in brain tumor-associated depression.

Bosnyák E, Kamson DO, Behen ME, Barger GR, Mittal S, Juhász C.

EJNMMI Res. 2015 Dec;5(1):56. doi: 10.1186/s13550-015-0136-9. Epub 2015 Oct 17.

3.

Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI.

Ye M, Yang T, Qing P, Lei X, Qiu J, Liu G.

PLoS One. 2015 Sep 1;10(9):e0133775. doi: 10.1371/journal.pone.0133775. eCollection 2015.

4.
5.

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder.

Nugent AC, Robinson SE, Coppola R, Furey ML, Zarate CA Jr.

Neuroimage. 2015 Sep;118:1-12. doi: 10.1016/j.neuroimage.2015.05.051. Epub 2015 May 30.

PMID:
26032890
6.

Role of NG2 expressing cells in addiction: a new approach for an old problem.

Somkuwar SS, Staples MC, Galinato MH, Fannon MJ, Mandyam CD.

Front Pharmacol. 2014 Dec 19;5:279. doi: 10.3389/fphar.2014.00279. eCollection 2014. Review.

7.

Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis.

Klimes-Dougan B, Eberly LE, Westlund Schreiner M, Kurkiewicz P, Houri A, Schlesinger A, Thomas KM, Mueller BA, Lim KO, Cullen KR.

Dev Psychopathol. 2014 Nov;26(4 Pt 2):1321-35. doi: 10.1017/S0954579414001059.

8.

Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders.

Williams NR, Taylor JJ, Lamb K, Hanlon CA, Short EB, George MS.

World J Radiol. 2014 Oct 28;6(10):756-78. doi: 10.4329/wjr.v6.i10.756. Review.

9.

Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study.

Rubinow MJ, Mahajan G, May W, Overholser JC, Jurjus GJ, Dieter L, Herbst N, Steffens DC, Miguel-Hidalgo JJ, Rajkowska G, Stockmeier CA.

Brain Struct Funct. 2016 Jan;221(1):171-84. doi: 10.1007/s00429-014-0900-z. Epub 2014 Oct 7.

PMID:
25287512
10.

Fetal hormonal programming of sex differences in depression: linking women's mental health with sex differences in the brain across the lifespan.

Goldstein JM, Holsen L, Handa R, Tobet S.

Front Neurosci. 2014 Sep 8;8:247. doi: 10.3389/fnins.2014.00247. eCollection 2014. No abstract available.

11.

Abnormal amygdala resting-state functional connectivity in adolescent depression.

Cullen KR, Westlund MK, Klimes-Dougan B, Mueller BA, Houri A, Eberly LE, Lim KO.

JAMA Psychiatry. 2014 Oct;71(10):1138-47. doi: 10.1001/jamapsychiatry.2014.1087.

12.

Reduced intrinsic connectivity of amygdala in adults with major depressive disorder.

Ramasubbu R, Konduru N, Cortese F, Bray S, Gaxiola-Valdez I, Goodyear B.

Front Psychiatry. 2014 Feb 19;5:17. doi: 10.3389/fpsyt.2014.00017. eCollection 2014.

13.

Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorder.

Young KD, Zotev V, Phillips R, Misaki M, Yuan H, Drevets WC, Bodurka J.

PLoS One. 2014 Feb 11;9(2):e88785. doi: 10.1371/journal.pone.0088785. eCollection 2014.

14.

Tractography of the brainstem in major depressive disorder using diffusion tensor imaging.

Song YJ, Korgaonkar MS, Armstrong LV, Eagles S, Williams LM, Grieve SM.

PLoS One. 2014 Jan 21;9(1):e84825. doi: 10.1371/journal.pone.0084825. eCollection 2014.

15.

Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Goldstein JM, Handa RJ, Tobet SA.

Front Neuroendocrinol. 2014 Jan;35(1):140-58. doi: 10.1016/j.yfrne.2013.12.001. Epub 2013 Dec 16. Review.

16.

Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.

Anderson SA, Michaelides M, Zarnegar P, Ren Y, Fagergren P, Thanos PK, Wang GJ, Bannon M, Neumaier JF, Keller E, Volkow ND, Hurd YL.

J Clin Invest. 2013 Dec;123(12):5334-41. doi: 10.1172/JCI70395. Epub 2013 Nov 15.

17.

Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.

Sublette ME, Milak MS, Galfalvy HC, Oquendo MA, Malone KM, Mann JJ.

Arch Suicide Res. 2013;17(4):434-47. doi: 10.1080/13811118.2013.801813.

18.

Serotonin transporter genotype modulates functional connectivity between amygdala and PCC/PCu during mood recovery.

Fang Z, Zhu S, Gillihan SJ, Korczykowski M, Detre JA, Rao H.

Front Hum Neurosci. 2013 Oct 31;7:704. doi: 10.3389/fnhum.2013.00704. eCollection 2013.

19.

HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression.

Holsen LM, Lancaster K, Klibanski A, Whitfield-Gabrieli S, Cherkerzian S, Buka S, Goldstein JM.

Neuroscience. 2013 Oct 10;250:733-42. doi: 10.1016/j.neuroscience.2013.07.042. Epub 2013 Jul 25.

20.

Toward a neuroimaging treatment selection biomarker for major depressive disorder.

McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, Craddock RC, Mayberg HS.

JAMA Psychiatry. 2013 Aug;70(8):821-9. doi: 10.1001/jamapsychiatry.2013.143.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk